Tuesday, November 12, 2013

Mandragora officinarum & CLAVIS

The second issue of the Clavis Journal features the painting, Mandragora officarum, as a companion illustration for an article about the infamous Mandrake plant. Also included in this issue is the painting, The Path, alongside artworks by other notable peers and colleagues including Madeline von Foerster, Hagen von Tulien, and Timo Ketola.

The second issue of the journal will be officially released Saturday, the 16th of November, at the Anna Miliksetian | MJBrigss Gallery in Los Angeles. Two Vierling paintings will be on display at the event. Interested collectors please contact the Clavis Journal for more information.

From the Clavis Website:

Clavis Journal is a book-quality occult periodical published every nine months by Clavis Editions, a collaborative endeavor between Three Hands Press and Ouroboros Press. At over 200 pages, its second volume contains 17 essays by some of the most cogent esoteric authors of our time, including Henrik Bogdan, Gordan Djurdjevic, Andrew D. Chumbley, and Gemma Gary. Volume 2 builds upon the tradition established in our maiden volume: ”A Journal of Occult Arts, Letters, and Experience“.

To mark its release, an official launch party will be held on Saturday the 16th of November in Los Angeles, California from 7:00-10:00 PM at Anna Meliksetian | MJBriggs Gallery. Our guest speaker will be Gordan Djurdjevic, who will give a brief talk on the Thelemic goddess Babalon, the subject of his essay in CLAVIS 2.

The event will also feature the exhibited artworks Tom Allen, Billy Davis, Caroline Hamilton-Giles, Carlos Melgoza and Benjamin Vierling whose work appears along with other artists in Volume 2. Several of the artists will be in attendance, and refreshments will be served.

Ouroboros Press and Three Hands Press titles will be on hand for sale, as will be selections of original art from our artists. Announcements on future works from the publishers will also be made.

To order a copy of the journal, please visit the Clavis website. 

No comments:

Post a Comment